Carasent
ISIN
NO0010123060
Ticker
CARA
Sector
Sub-Industry
Country
Norway
Year Founded
1997
ISIN
NO0010123060
Ticker
CARA
Sector
Sub-Industry
Country
Norway
Year Founded
1997
Carasent ASA was founded in 1997. In May 2018, the Swedish company Evimeria EMR AB, a provider of cloud-based medical record services to the healthcare industry, was acquired. Since then, the company has grown steadily both organically and through M&As.
Today Carasent includes six subsidiaries: Evimeria EMR AB, Carasent Norge ASA, Metodika EMR, Medrave, Confrere and HPI. Our customers range from primary care, specialist clinics to rehabilitation and occupational health.
Our mission is to develop and provide the most comprehensive and innovative business support solutions for health and care organisations.
Worldwide
| Line item in (nok) | 01.01.2020 | 01.01.2021 | 01.01.2022 | 01.01.2023 |
|---|---|---|---|---|
| Assets | N/A | 504,949,000.00 | 1,300,818,000.00 | 1,370,898,000.00 |
| Noncurrent Assets | N/A | 267,011,000.00 | 391,354,000.00 | 636,688,000.00 |
| Other Property Plant And Equipment | N/A | 1,198,000.00 | 1,507,000.00 | 3,030,000.00 |
| Goodwill | N/A | 170,339,000.00 | 271,990,000.00 | 385,181,000.00 |
| Other Intangible Assets | N/A | N/A | 0.00 | 1,437,000.00 |
| Deferred Tax Assets | N/A | 1,117,000.00 | 327,000.00 | 0.00 |
| Current Assets | N/A | 237,938,000.00 | 909,465,000.00 | 734,210,000.00 |
| Current Trade Receivables | N/A | 11,071,000.00 | 20,093,000.00 | 27,575,000.00 |
| Current Prepaid Expenses | N/A | 2,195,000.00 | 2,161,000.00 | 6,692,000.00 |
| Other Current Receivables | N/A | 3,517,000.00 | 3,455,000.00 | 2,667,000.00 |
| Cash and cash equivalents | 10,928,000.00 | 221,155,000.00 | 883,756,000.00 | 697,276,000.00 |
| Equity And Liabilities | N/A | 504,949,000.00 | 1,300,818,000.00 | 1,370,898,000.00 |
| Equity | 90,577,000.00 | 400,975,000.00 | 1,171,274,000.00 | 1,226,601,000.00 |
| Issued Capital | N/A | 73,307,000.00 | 104,719,000.00 | 106,055,000.00 |
| Retained Earnings | N/A | -36,290,000.00 | -36,440,000.00 | -5,269,000.00 |
| Additional Paidin Capital | N/A | 354,630,000.00 | 1,105,556,000.00 | 1,136,377,000.00 |
| Warrant Reserve | N/A | N/A | 0.00 | 1,600,000.00 |
| Equity Attributable To Owners Of Parent | N/A | 400,975,000.00 | 1,171,274,000.00 | 1,226,601,000.00 |
| Noncurrent Liabilities | N/A | 62,816,000.00 | 20,497,000.00 | 50,311,000.00 |
| Deferred Tax Liabilities | N/A | 8,873,000.00 | 9,864,000.00 | 12,945,000.00 |
| Other Noncurrent Liabilities | N/A | N/A | 0.00 | 8,517,000.00 |
| Longterm Borrowings | N/A | N/A | 0.00 | 625,000.00 |
| Current Liabilities | N/A | 41,158,000.00 | 109,047,000.00 | 93,985,000.00 |
| Trade And Other Current Payables To Trade Suppliers | N/A | 4,883,000.00 | 8,942,000.00 | 20,245,000.00 |
| Current Contract Liabilities | N/A | 6,930,000.00 | 17,506,000.00 | 25,029,000.00 |
| Accruals Classified As Current | N/A | 14,840,000.00 | 24,027,000.00 | 26,393,000.00 |
| Other Current Liabilities | N/A | 8,759,000.00 | 6,630,000.00 | 12,285,000.00 |
| Line item in (nok) | 01.01.2020/ 01.01.2021 |
01.01.2021/ 01.01.2022 |
01.01.2022/ 01.01.2023 |
|---|---|---|---|
| Revenue | 70,576,000.00 | 137,125,000.00 | 195,260,000.00 |
| Employee Benefits Expense | 21,895,000.00 | 47,274,000.00 | 82,739,000.00 |
| Depreciation And Amortisation Expense | 12,629,000.00 | 23,336,000.00 | 34,081,000.00 |
| Other Expense By Nature | 18,835,000.00 | 32,643,000.00 | 45,961,000.00 |
| Profit Loss From Operating Activities | 3,427,000.00 | 9,646,000.00 | -1,361,000.00 |
| Profit Loss Before Tax | -35,672,000.00 | 3,734,000.00 | 33,874,000.00 |
| Income Tax Expense Continuing Operations | 2,459,000.00 | 3,882,000.00 | 2,704,000.00 |
| Profit (loss) | -38,131,000.00 | -148,000.00 | 31,170,000.00 |
| Profit Loss Attributable To Owners Of Parent | -38,131,000.00 | -148,000.00 | 31,170,000.00 |
| Line item in (nok) | 01.01.2020 | 01.01.2021 | 01.01.2022 | 01.01.2023 |
|---|---|---|---|---|
| Profit (loss) | N/A | -38,131,000.00 | -148,000.00 | 31,170,000.00 |
| Adjustments For Increase Decrease In Trade Account Payable | N/A | 1,148,000.00 | 2,558,000.00 | 10,079,000.00 |
| Adjustments For Depreciation And Amortisation Expense | N/A | 12,629,000.00 | 23,336,000.00 | 34,081,000.00 |
| Adjustments For Sharebased Payments | N/A | 38,400,000.00 | 0.00 | 2,169,000.00 |
| Adjustments For Fair Value Gains Losses | N/A | N/A | 5,061,000.00 | -39,334,000.00 |
| Cash Flows From Used In Operating Activities | N/A | 18,761,000.00 | 32,480,000.00 | 33,612,000.00 |
| Cash Flows Used In Obtaining Control Of Subsidiaries Or Other Businesses Classified As Investing Activities | N/A | 59,993,000.00 | 86,897,000.00 | 104,885,000.00 |
| Cash Flows From Used In Investing Activities | N/A | -76,125,000.00 | -125,124,000.00 | -209,500,000.00 |
| Proceeds From Issuing Shares | N/A | 286,468,000.00 | 790,758,000.00 | 5,475,000.00 |
| Repayments Of Borrowings Classified As Financing Activities | N/A | 1,234,000.00 | 0.00 | 158,000.00 |
| Payments Of Lease Liabilities Classified As Financing Activities | N/A | 2,302,000.00 | 4,867,000.00 | 7,191,000.00 |
| Interest Paid Classified As Financing Activities | N/A | 687,000.00 | 646,000.00 | 1,279,000.00 |
| Cash Flows From Used In Financing Activities | N/A | 268,318,000.00 | 756,562,000.00 | -10,195,000.00 |
| Effect Of Exchange Rate Changes On Cash And Cash Equivalents | N/A | -727,000.00 | -1,317,000.00 | -398,000.00 |
| Increase (decrease) in cash and cash equivalents after effect of exchange rate changes | N/A | 210,227,000.00 | 662,601,000.00 | -186,481,000.00 |
| Cash and cash equivalents | 10,928,000.00 | 221,155,000.00 | 883,756,000.00 | 697,276,000.00 |
Please note that some sums might not add up.
NO0010123060
5967007LIEEXZXI9ZS60
Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.